CME Group (NASDAQ:CME) Director Sells $91,770.00 in Stock

CME Group Inc. (NASDAQ:CME - Get Free Report) Director Martin Gepsman sold 300 shares of the company's stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $305.90, for a total transaction of $91,770.00. Following the completion of the sale, the director directly owned 24,999 shares in the company, valued at approximately $7,647,194.10. The trade was a 1.19% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

CME Group Trading Up 1.4%

• Higher-for-Longer Rates Could Reward These 3 Overlooked Stocks

CME stock opened at $308.09 on Friday. CME Group Inc. has a twelve month low of $246.91 and a twelve month high of $309.35. The company has a market cap of $111.10 billion, a P/E ratio of 27.61, a PEG ratio of 3.56 and a beta of 0.27. The company has a quick ratio of 1.02, a current ratio of 1.03 and a debt-to-equity ratio of 0.12. The business has a fifty day moving average of $283.19 and a 200-day moving average of $274.85.

CME Group (NASDAQ:CME - Get Free Report) last announced its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.75 by $0.02. The business had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.64 billion. CME Group had a return on equity of 14.65% and a net margin of 62.45%.CME Group's revenue for the quarter was up 8.1% compared to the same quarter last year. During the same quarter last year, the firm earned $2.52 EPS. As a group, equities research analysts expect that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Increases Dividend

---

---

• Gold, Silver, and Copper Are Surging—Here Are 3 Smart Ways to Play It

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 26th. Stockholders of record on Tuesday, March 10th will be issued a dividend of $1.30 per share. This is an increase from CME Group's previous quarterly dividend of $1.25. The ex-dividend date of this dividend is Tuesday, March 10th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.7%. CME Group's payout ratio is presently 46.59%.

Hedge Funds Weigh In On CME Group

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Caldwell Trust Co boosted its stake in shares of CME Group by 116.3% during the 3rd quarter. Caldwell Trust Co now owns 93 shares of the financial services provider's stock valued at $25,000 after buying an additional 50 shares during the last quarter. Asset Dedication LLC grew its position in CME Group by 64.9% in the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider's stock worth $26,000 after acquiring an additional 37 shares in the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA bought a new position in CME Group during the third quarter valued at about $27,000. FNY Investment Advisers LLC acquired a new stake in shares of CME Group in the fourth quarter worth $27,000. Finally, Elkhorn Partners Limited Partnership acquired a new position in shares of CME Group during the 4th quarter worth about $27,000. Institutional investors and hedge funds own 87.75% of the company's stock.

Key Stories Impacting CME Group

• Capitalize on Volatility: 3 Finance Stocks Thriving in 2025

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME’s formal announcement to offer 24/7 trading for crypto futures and options — a move that addresses the timing gap with always‑on spot crypto markets and could lift ADV and fee revenue; the company cited record crypto notional volume in 2025. CME Group to Launch 24/7 Cryptocurrency Futures and Options Trading on May 29
• Positive Sentiment: Widespread coverage emphasizes the practical impacts — continuous trading can reduce “CME gaps,” boost institutional flow and expand crypto derivatives ADV, supporting the bullish thesis for trading‑fee growth. CME targets May launch for 24/7 crypto derivatives trading
• Positive Sentiment: Analyst/fin‑media bullishness — some outlets include CME among top picks, arguing the firm converts market volatility into trading revenue, which supports the stock’s rally. 2 Best Stocks to Buy Right Now for February
• Neutral Sentiment: Macro/market context — broader market moves (small‑cap rotation and sector flows) could be influencing intraday moves in financials/exchanges but are not specific to CME’s fundamentals. Small Caps Stage Quiet Comeback As AI Trade Shows Cracks
• Neutral Sentiment: Reported short‑interest data appears immaterial or inconsistent (no meaningful change reported); it isn’t currently signaling a large positioning risk.
• Negative Sentiment: Insider selling — director Martin J. Gepsman sold 300 shares; small in size but noteworthy as a disclosed insider sale. Insider Sale: Martin J. Gepsman
• Negative Sentiment: Critical takeaways — at least one outlet warns of risks to the CME thesis (valuation and competitive/operational risks), which could temper enthusiasm if amplified by further negative coverage. 2 Reasons CME is Risky and 1 Stock to Buy Instead

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on CME shares. JPMorgan Chase & Co. raised their target price on shares of CME Group from $262.00 to $266.00 and gave the company an "underweight" rating in a research note on Thursday, February 5th. Argus reduced their target price on shares of CME Group from $308.00 to $295.00 in a report on Friday, October 31st. Piper Sandler lifted their price objective on shares of CME Group from $296.00 to $313.00 and gave the company an "overweight" rating in a research report on Thursday, November 13th. Barclays boosted their price objective on shares of CME Group from $304.00 to $312.00 and gave the company an "equal weight" rating in a research report on Thursday, February 5th. Finally, Rothschild & Co Redburn raised their target price on shares of CME Group from $300.00 to $333.00 and gave the company a "neutral" rating in a research report on Thursday, February 12th. Nine research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company's stock. Based on data from MarketBeat.com, CME Group presently has a consensus rating of "Hold" and a consensus price target of $299.53.

View Our Latest Report on CME Group

CME Group Company Profile

(Get Free Report)

CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

Read More

• Five stocks we like better than CME Group
• The gold chart Wall Street is terrified of…
• Buy this Gold Stock Before May 2026
• What a Former CIA Agent Knows About the Coming Collapse
• This $15 Stock Could Go Down as the #1 Stock of 2026
• New gold price target

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].